Literature DB >> 8991979

The assessment of functional status in rheumatoid arthritis: a cross cultural, longitudinal comparison of the Health Assessment Questionnaire and the Groningen Activity Restriction Scale.

D Doeglas1, B Krol, F Guillemin, T Suurmeijer, R Sanderman, L M Smedstad, S Briançon, W van den Heuvel.   

Abstract

OBJECTIVE: To compare a disease specific measure of functional status, the Health Assessment Questionnaire (HAQ) with a generic measure of functional status, the Groningen Activity Restriction Scale (GARS) in a cross cultural and longitudinal setting. Besides the comparison of psychometric properties, sex differences were also studied.
METHODS: In a sample of 634 patients with rheumatoid arthritis (RA) (290 from The Netherlands, 116 from France, 228 from Norway), the psychometric properties (Cronbach's alpha and rho) of the GARS and the HAQ were compared among countries. The sensitivity for change between T1 and T2 was tested by means of the standardized response mean for a one year followup; furthermore, the relative efficiency of both instruments was computed. A t test was used to trace sex differences.
RESULTS: The psychometric properties of both the HAQ and the GARS were very good. Both form unidimensional scales of hierarchically ordered items; alpha and rho are > 0.91 for both instruments. For patients who improved between T1 and T2, measured by the Ritchie Articular Index, the standardized response mean of the HAQ and the GARS were moderate, whereas for patients who worsened, the standardized response means were small. The results based on the relative efficiency were ambiguous. Furthermore, the mean score for women on the HAQ was 0.25 higher in contrast to scores for men. The GARS did not yield different scores for women and men.
CONCLUSION: The internal consistency of the GARS and the HAQ are comparable. The HAQ has yielded different results for women and men. Therefore, when the HAQ is used, sex differences should be taken into account. With respect to sensitivity to change, the GARS and the HAQ obtained much better results for patients who improved in contrast to patients who worsened. The GARS was found to be more sensitive to change for patients who improved.

Entities:  

Mesh:

Year:  1995        PMID: 8991979

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

Review 1.  Impairment measures in rheumatic disorders for rehabilitation medicine and allied health care: a systematic review.

Authors:  Raymond A H M Swinkels; Lex M Bouter; Rob A B Oostendorp; Cornelia H M van den Ende
Journal:  Rheumatol Int       Date:  2005-06-24       Impact factor: 2.631

2.  Disease activity and health status in rheumatoid arthritis: a case-control comparison between Norway and Lithuania.

Authors:  J Dadoniene; T Uhlig; S Stropuviene; A Venalis; A Boonen; T K Kvien
Journal:  Ann Rheum Dis       Date:  2003-03       Impact factor: 19.103

3.  Functional ability, social support, and depression in rheumatoid arthritis.

Authors:  D M Doeglas; Th P B M Suurmeijer; W J A van den Heuvel; B Krol; M H van Rijswijk; M A van Leeuwen; R Sanderman
Journal:  Qual Life Res       Date:  2004-08       Impact factor: 4.147

Review 4.  Sociodemographic differences in quality of life in rheumatoid arthritis.

Authors:  Erik J Groessl; Theodore G Ganiats; Andrew J Sarkin
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 5.  Measurement properties of physical function scales validated for use in patients with rheumatoid arthritis: a systematic review of the literature.

Authors:  Martijn A H Oude Voshaar; Peter M ten Klooster; Erik Taal; Mart A F J van de Laar
Journal:  Health Qual Life Outcomes       Date:  2011-11-07       Impact factor: 3.186

6.  Comparison of alternative full and brief versions of functional status scales among older adults in China.

Authors:  Jeremy Reich; Mark G Thompson; Benjamin J Cowling; A Danielle Iuliano; Carolyn Greene; Yuyun Chen; Rachael Phadnis; Nancy H L Leung; Ying Song; Vicky J Fang; Cuiling Xu; Qigang Dai; Jun Zhang; Hongjun Zhang; Fiona Havers
Journal:  PLoS One       Date:  2020-08-11       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.